JP Marolleau

1.5k total citations
29 papers, 933 citations indexed

About

JP Marolleau is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, JP Marolleau has authored 29 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 9 papers in Genetics. Recurrent topics in JP Marolleau's work include Lymphoma Diagnosis and Treatment (15 papers), Immune Cell Function and Interaction (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). JP Marolleau is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Immune Cell Function and Interaction (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). JP Marolleau collaborates with scholars based in France, United Kingdom and Belgium. JP Marolleau's co-authors include Tawfiq Henni, Philippe Gaulard, JP Le Couedic, Marine Diviné, Corinne Haïoun, MF Gourdin, Michel Goossens, JP Farcet, M Benbunan and Brendan Smith and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Cancer.

In The Last Decade

JP Marolleau

29 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JP Marolleau France 13 455 362 225 225 200 29 933
Gabriella Pichert Switzerland 21 541 1.2× 507 1.4× 258 1.1× 184 0.8× 189 0.9× 46 1.5k
Pascale De Paepe Belgium 15 387 0.9× 564 1.6× 285 1.3× 233 1.0× 140 0.7× 36 999
John Dervenoulas Greece 17 214 0.5× 238 0.7× 201 0.9× 168 0.7× 345 1.7× 56 940
Marie Maerevoet Belgium 15 415 0.9× 179 0.5× 147 0.7× 141 0.6× 92 0.5× 40 820
C Gisselbrecht France 15 451 1.0× 543 1.5× 181 0.8× 177 0.8× 97 0.5× 36 860
Jee Sook Hahn South Korea 19 531 1.2× 498 1.4× 222 1.0× 161 0.7× 244 1.2× 57 1.2k
Mark A. Arnesen United States 11 445 1.0× 573 1.6× 397 1.8× 131 0.6× 231 1.2× 12 1.2k
Jens Krugmann Austria 18 402 0.9× 432 1.2× 229 1.0× 142 0.6× 82 0.4× 41 857
Daoud Rahal Italy 17 598 1.3× 276 0.8× 81 0.4× 214 1.0× 102 0.5× 46 999
Sang Eun Yoon South Korea 16 537 1.2× 475 1.3× 110 0.5× 259 1.2× 92 0.5× 102 949

Countries citing papers authored by JP Marolleau

Since Specialization
Citations

This map shows the geographic impact of JP Marolleau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JP Marolleau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JP Marolleau more than expected).

Fields of papers citing papers by JP Marolleau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JP Marolleau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JP Marolleau. The network helps show where JP Marolleau may publish in the future.

Co-authorship network of co-authors of JP Marolleau

This figure shows the co-authorship network connecting the top 25 collaborators of JP Marolleau. A scholar is included among the top collaborators of JP Marolleau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JP Marolleau. JP Marolleau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chèze, S., Stéphane Girault, Pascal Turlure, et al.. (2023). Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial. Leukemia Research. 129. 107058–107058. 6 indexed citations
2.
Dufour, Jean‐François, Sylvain Choquet, Khê Hoang‐Xuan, et al.. (2023). Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study. Annals of Hematology. 102(5). 1159–1169. 2 indexed citations
3.
Paccou, Julien, Éric Desailly, Bérengère Gruson, et al.. (2014). Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study. Annals of Oncology. 25(2). 481–486. 28 indexed citations
4.
Etienne, A., Denis Chatelain, Réda Garidi, et al.. (2009). Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review. Advances in Hematology. 2009. 1–5. 7 indexed citations
5.
Arnulf, Bertrand, Séverine Lecourt, Jean Soulier, et al.. (2006). Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia. 21(1). 158–163. 154 indexed citations
6.
Cottu, Paul, et al.. (2001). Residual Tumor Cell Contamination in Peripheral Blood Stem Cells Collections of 117 Breast Cancer Patients Evaluated by Immunocytochemical Technique. Journal of Hematotherapy & Stem Cell Research. 10(6). 855–862. 4 indexed citations
7.
Haïoun, Corinne, Nicolas Mounier, Bruno Quesnel, et al.. (2001). Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: A pilot study of 36 patients. Annals of Oncology. 12(12). 1749–1755. 12 indexed citations
8.
Desgrandchamps, F., JP Marolleau, P Bertheau, et al.. (1999). The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer. British Journal of Cancer. 81(5). 832–834. 15 indexed citations
9.
Lefrère, François, et al.. (1999). Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma. Bone Marrow Transplantation. 24(5). 463–466. 18 indexed citations
10.
Borgen, Elin, Bjørn Naume, Jahn M. Nesland, et al.. (1999). Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy. 1(5). 377–388. 231 indexed citations
11.
Socié, Gèrard, JM Cayuela, B Raynal, et al.. (1998). Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation. Leukemia. 12(9). 1440–1446. 8 indexed citations
12.
Marolleau, JP, et al.. (1998). T cell repertoire of human umbilical cord blood.. PubMed. 22 Suppl 1. S39–40. 3 indexed citations
15.
Bastion, Y, Corinne Haïoun, Anne Sonet, et al.. (1995). Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood. 86(8). 3257–3262. 6 indexed citations
16.
Brice, Pauline, Jean Trédaniel, Jean-Jacques Monsuez, et al.. (1991). Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin’s disease. Annals of Oncology. 2 Suppl 2. 73–76. 33 indexed citations
17.
Brice, Pauline, Jean Trédaniel, Jean-Jacques Monsuez, et al.. (1991). Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's disease. Annals of Oncology. 2. 73–76. 19 indexed citations
18.
Brice, Pauline, JP Marolleau, M F D'Agay, B Epardeau, & C Gisselbrecht. (1991). Autoimmune hemolytic anemia disclosing Hodgkin's disease associated with Castleman's disease.. PubMed. 33(3). 273–4. 5 indexed citations
19.
Farcet, JP, Philippe Gaulard, JP Marolleau, et al.. (1990). Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 75(11). 2213–2219. 14 indexed citations
20.
Farcet, J P, MF Gourdin, Marine Diviné, et al.. (1988). Activation by PHA of CD8 lymphocytes into clonal colony forming cells. Journal of Immunological Methods. 110(2). 241–249. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026